Streptogramin analogues

References

• VAZQUEZ D: The streptogramin family of antibiotics. In: Antibiotics. (1975) Corcoran JN, Hahn FE (Eds), Springer, Berlin, Heidelberg, New-York, V01.111:521–534.
   Google Scholar
• The first review on streptogramins.
   Google Scholar
• COCITO C: Antibiotics of the virginia.mycin family, inhibitors which contain synergistic components. Mi-crobiological Reviews (1979) 43(2):145–198.
   Google Scholar
• The reference article on the properties of yirginiamycin-like antibi-otics.
   Google Scholar
• PARIS JM, BARRIERE JC, SMITH C, BOST PE: The chemistry of pristinamycin. In: Recent Progress in the ChemicalSynthesis of Antibiotics (1990) Lukacs G, Ohno M (Eds), Springer Verlag, Berlin, Heidelberg, p183–248.
   Google Scholar
• An overview on the chemistry of streptogramins.
   Google Scholar
• BARRIERE JC, PARIS JM: RP 59500 and related semisyn- thetic streptogramins. Drugs of the Future (1993),18(9):833–845.
   Google Scholar
• A recent review on RP 59500 and pristinamycins.
   Google Scholar
• BARRIERE JC, BOUANCHAUD D, HARRIS NV, PARIS JM, SMITH C: The design, synthesis and properties of RP 59500 and related semi-synthetic streptogramin antibi- otics. 30113 International Conference On Antimicrobial Agents Anti Chemotherapy, Atlanta, (1990), Abstr. 768.
   Google Scholar
• BARIUERE JC, BOUANCHAUD DH, PARIS JM, ROLIN O,HARRIS NV, SMITH C: Antimicrobial activity against Staphylococcus aureus of semi-synthetic injectable steptogramins: RP59500 and related compounds. J. An-timicrob. Chemother. (1992) 30(Suppl A):1–8.
   Google Scholar
• SILVER LL, BOSTIAN KA: Discovery and development ofnew antibiotics: The problem of antibiotic resistance. Antimicrobial Agents and Chemotherapy (1993) 37(3):377–383.
   PubMed Web of Science ®Google Scholar
• NEU H: The crisis in antibiotic resistance. Science(1992)257:1064–1072.
   PubMed Web of Science ®Google Scholar
• BARRETT JF, KLAUBERT DH: Is the new streptograminderivative the answer to MRSA? Curr. Opin. Invest. Drugs (1993) 2(3):245–247.
   Google Scholar
• MARTINELLI E, ZERILLI LF, VOLPE G, PAGANI E CARELLIB: New antibiotics fromActinoplanes strains. Structure of A 17002 C. J. Antibiotics (1979):108–114.
   Google Scholar
• CHAMBERLAIN JW, CH:EN S: A2315, New antibiotics pro-duced byActinoplanes pbilippinensis. 2. Structure of A 2315A. J. Antibiotics (1977) 30(3):197–201.
   Google Scholar
• BRAZHUIKOVA MG, KUDINOVA MK, POPATOVA P, FIL-LIPOVA TM, BOROWSKI E, ZELINSKY P, GOLIC J: Structure of the antibiotic madumycin. Bioorg. Khim.(1976) 2:149–157.
   Web of Science ®Google Scholar
• WEN-CHIH L, SEINER V, DEAN ID, TREJO WH, PRINCIPEPA, MEYERS E, SYKES RB: Production of vernamycin by a Micromonospora. J. Antibiotics (1981) 34(11):1515–1516.
   PubMed Web of Science ®Google Scholar
• CORSI M, POJANI G, DAL FORNO G, PIETRA C, GAVIRAGHIG, TRIST D: Analysis of the CCKB receptor antagonism of virginiamycin In guinea-pig ileum longitudinal myenteric plexus. Br.J. Pharmacol. (1993) 108:1164–1168.
   PubMed Web of Science ®Google Scholar
• LAM YKT, BOGEN D, CHANG RS, FAUST ICA, HENSENS OD,ZINK DL, SCHWARTZ CD, ZITANO L, GARRITY GM, GAGLIARDI MM, CURRIE SA, WOODDRUFF HB: Novel and potent gastrin and brain cholecystokinin antagonist from Streptomyces olivaceus. Taxonomy, fermenta-tion, isolation, chemical conversions, and physico-chemical and biochemical properties. J. Antibiotics (1990) 44(6):613–625.
   Google Scholar
• OKUMURA Y: Directed biosynthesis of neoviridogrise-ins. In: Biochemistry of Peptide Antibiotics, (1990) Kleinkauf H and von Döhren (Eds), W de Gruyter, Berlin, N-Y, p365–378.
   Google Scholar
• VIDEAU D: Etude de l'activité bactericide de la pristi-namycine IA Path. Biol. (1982) 30:529–534.
   Google Scholar
• COCITO C: Properties of virginiamycin-like antibiotics (synergimycins), inhibitors containing synergisticcomponents In: Antibiotics, Corcoran JN, Hahn FE (Eds), Springer, Berlin, Heidelberg, New York (1983), Vol VI:296–332.
   Google Scholar
• An important contribution in reviewing the properties of the strep-togramins.
   Google Scholar
• COCITO C, CHINALI G: Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on the protein synthesis in bacterial cell-free systems. J. Antimicrob. Chernother. (1985) 16(Suppl. A):35–52.
   Google Scholar
• A molecular explanation of the synergistic action of yirginiamycin antibiotics in vim is given.
   Google Scholar
• DI GAMBATTISTA M, ENGELBORGHS Y, NYSSEN E, CO-CITO C: Kinetics of binding of macrolides, lin-cosamides, and synergimycins to ribosomes. J Biol. Chem. (1987) 262:8591–8597.
   PubMed Web of Science ®Google Scholar
• DI GAMBATTISTA M, CHINALI G, COCITO C: The molecu-lar basis of the inhibitory activities of the type A and type B synergirnycins and related antibiotics on ribo-somes. J. Antimicrob. Chemother. (1989) 24:485–507.
   PubMed Web of Science ®Google Scholar
• AUMERCIER M, BOUHALLAB S, CAPMAU ML, LE GOFFIC F:RP59500: A proposed mechanism for its bactericidal activity. J. Antimicrob. Chemother. (1992) 30 (Suppl. A):9–14.
   Google Scholar
• DI GAMBATTISTA M, ENGELBORGHS Y, NYSSEN E, CLAYS K, COCITO C: Interaction between virginiamycin S and ribosomes is partly provided by a salt bridge with a Mg2+ ion. Biochemistry (1991) 30:7277–7282.
   PubMed Web of Science ®Google Scholar
• A relevant article on the biological importance of the 3-hydroxy picolinic acid residue in group B streptogramins.
   Google Scholar
• DI GAMBATTISTA M, NYSSEN E, PECHER A, COCITO C: Affinity labelling of the virginiamycin S binding site onbacterial ribosome. Biochemistry (1990) 29:9203-9211. An advance in the mechanism of action of streptogramins.
   Google Scholar
• VANNUFFEL P, DI GAMBATTISTA, M COCITO C: The role of RNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. J. Biol. Chem. (1992) 267:16114–16120.
   PubMed Web of Science ®Google Scholar
• ANTEUNIS MJO, CALLENS R, SHARMA NK: Carboxymethy-lation of keto substrates. A useful grafting procedure applied on virginiamycin factors A and B. Bull. Chem. Soc Chim. Beiges (1988) 97:209–217.
   Google Scholar
• LAM TYK, ZINK DL, SMITH AJ, LEE NW, FREEDMAN S, SALVATORE MJ: New virginiamycin M1 derivatives: Syn-thesis, cholecystokinin binding inhibitory and antimi-crobial properties. J Antibiotics (1992) 46(4):623–630.
   Web of Science ®Google Scholar
• KESSLER H, KUTSCHER B, MAGER G AND GRELL E: Syn-these des streptogramin-B-analogen cyclodepsipeptid cycloE-(Boc)Ser-D-Abu-Pro-(Me)Phe-Pip-Phg-0]. Liebigs Ann.Chem. (1983) 1541–1550.
   Google Scholar
• SHARMA NK, ANTEUNIS MJO: Benzylation of virginiaray-cin Si. Bull. Soc. Chim. Beiges (1988) 97:365–369.
   Google Scholar
• SHARMA NK, ANTEUNIS MJO: A search for phenolic protection in virghllarnycin S. Bull. Soc. Chim. Beiges (1989) 98:463–479.
   Google Scholar
• MOERMAN MC, ANTEUNIS MJO: Unique 1'-0 Boc protec-tion of virginiarnycin Sand resulting resistance against sodium hydroxide. Bull. Soc. Chim. Belges (1991) 100:647–651.
   Google Scholar
• DI GAMBATTISTA M, SHARMA NK, ANTEUNIS MJO: Some simple conjugates of virginiamycin and their bio-activ-ity. Bull. Soc. Chim. Beiges (1990) 99:195–211.
   Google Scholar
• ANTEUNIS MJO, VAN DER AUWERA, VANFLETEREN L, BORREMANS F: The synthesis of a Ny- phthalyl-Na - methyl-a-7 diaminobutyryl congener of virginiamycin Si. Bull .Soc. Chim. Beiges (1988) 97:135–148.
   Google Scholar
• MOERMAN MC, ANTEUNIS MJO: Partial synthesis of five analogues of the peptido lactone Virginiamycin modified in the fifth and/or sixth position ([Xxx5]-VS1 with Xxx = Ala, Asp, Asn and Lys and [A1a5,G1y61-VS1). Int. J. Peptide Protein Res. (1993) 41:102–117.
   PubMedGoogle Scholar
• AUCICENTHALER R, BAQUERO F, BRAVENY I, DORN-BUSCH K, DUVAL J, FLEURETTE J, GEORGOPOULOS A, KAYSER FH, PRIVITERA G, ROHNER P, SITAVANC R, WIL-LIAMS JD: In vitro activity of RP 59500 against staphylo-cocci: European multicenter study. 31st International Conference On Antimicrobial Agents And Chemotherapy Chicago, (1991), Abstr. 900.
   Google Scholar
• ARCHER G, AUGER P, DOERS G, FERRARO MJ, FUCHS P, JORGENSEN J, LOW D, MURRAY P, RELLER LB, STRATTON C, WENNERSTEN, MOELLERING RC: RP 59500, a new streptogramin highly active against recent isolates of North American staphylococcL Diagn. Microbiol. Infect. Dis.(1993) 16(3):223–226.
   PubMed Web of Science ®Google Scholar
• An important contribution to the evaluation of RP 59500
   Google Scholar
• FREMAUX A, SISSIA G, COHEN R, GESLIN P: In vitroactivity of RP 59500, a new setnisynthetic strepto-gramin, against Streptococcus pneumoniae. J. Antimi-crob. Chemother. (1992) 30 (Suppl. A):19–24.
   Google Scholar
• APPELBAUM PC, SPANGLER SK, JACOBS MR: Susceptibilityof 139 penicillin-susceptible and resistant isolates of Streptococcus pneumoniae to RP 59500, erythromycin, vancomycin, temafloxacin, ciprofloxacin and oflox-acin. 31st International Conference On Antimicrobial Agents And Chemotherapy Chicago, (1991) Abstr. 893.
   Google Scholar
• VERBIST L, VERHAEGEN J: Comparative in vitro activityof RP 59500. J. Antimicrob. Chemother. (1992) 30(Suppl. A):39–44.
   Google Scholar
• COLLINS L, MALANOSKI G, WENNERSTEN C, ELIOPOULOS MG, FERRARO MJ, MOELLERING RC: In vitro activity of RP 59500 an injectable streptogramin antibiotic, against vancomycin-resistant grain-positive organisms. 32nd International Conference On Antimicrobial Agents And Che-motherapy Anaheim, (1992), Abstr. 1311.
   Google Scholar
• SCRIVER SR, TYRRELL G, WILLEY BM, KREISWIRTH BN,LOW DE: In vitro assessment of RP 59500 (RP) against vancomycin-resistant enterococci 33rd International Conference On Antimicrobial Agents And Chemotherapy New Orleans, (1993), Abstr. 1057.
   Google Scholar
• COOPER B, ROBINSON A, FREEMAN C, QUINTILIANI II R,MAZENS-SULLTVAN M, NIGHTINGALE C, QUINTILIANI R: Antimicrobial susceptibility of vancomycin-resistant enterococci. 33rd International Conference On Antimicro-bial Agents And Chemotherapy New Orleans, (1993), Abstr. 1053.
   Google Scholar
• CASEWELL MW, SEYED-A/CHAVANI M, WADE J: In vitroactivity of RP 59500 against vancomycin-resistant En-terococcus faecium also resistant to 512mg/1 of gen-tamycin. 33rd International Conference On Antimicrobial Agents And Chemotherapy New Orleans,( 1993), Abstr. 1058.
   Google Scholar
• NEU HC, CHIN N, GU J: The in vitro activity of newstreptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination. J. Antimicrob. Chemother. (1992) 30(Suppl. A):83–94.
   Google Scholar
• DABERNAT H, SEGUY, DELMAS C: In vitro activity of RP59500, a semi-synthetic streptogramin, against Haemo-pbilus influenzae. 33rd International Conference On An-timicrobial Agents And Chemotherapy New Orleans, (1993), Abstr. 226.
   Google Scholar
• ANDREW JM, BASWELL F, WISE R: In vitro activity of RP59500 against staphylococci and respiratory patho-gens. 33rd International Conference On Antimicrobial Agents and Chemotherapy New Orleans, US (1993): Abstr. 1044. 72. cc
   Google Scholar
• DUBOIS J, JOLY JR: In vitro activity of RP 59500, a new synergistic antibacterial agent, against Legionella spp. J. Antimicrob. Chemother. (1992) 30(Suppl. A):77–82.
   Google Scholar
• SOUSSY CJ, ACAR JF, CLUZEL R, COURVALIN P, DUVAL J, FLEURETTE J, MEGRAUD, MEYRAN M, THABAUT A: A collaborative study of the in vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. J. Antimicrob. Chemother. (1992) 30(Suppl. A):53–58.
   Google Scholar
• RENAUDIN H, BOUSSENS B, BEBEAR C: In vitro activity of RP 59500 against Mycoplasnsa. 31st International Conference On Antimicrobial Agents And Chemotherapy Chicago, (1991), Abstr. 897.
   Google Scholar
• BOUANCHAUD DH: unpublished data.
   Google Scholar
• WISE R: unpublished data.
   Google Scholar
• LECLERCQ R, NANTAS L, SOUSSY CJ, DUVAL J: Activity of RP 59500, a new parenteral sennlsynthetic strepto-gramin, against staphylococci with various mecha-nisms of resistance to macrolide-lincosamide-streptogramki antibiotics. J. Antimicrob. Chemother. (1992) 30(Suppl. A):67–76.
   Google Scholar
• EL SOLH N, LONCLE V, AUBERT S, CASETTA A, ALLIGNET J: Analysis of Staphylococcal elements conferring resis-tance to streptogramin A (RP 54476). 33rd International Conference On Antimicrobial Agents And Chemotherapy New Orleans, (1993), Abstr. 217.
   Google Scholar
• HOBAN DJ, WESNOWESKI B, PALATNICK L, ZHANEL CJ, DAVIDSON RJ: In vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal ki-netic studies. J. Antimicrob. Chemother. (1992) 30(Suppl. A):59–66.
   Google Scholar
• BRUMEIIT W, HAMILTON-MILLER JMT, SHAH S: In vitro activity of RP 59500, a new semisynthetic strepto-gramin, against Gram-positive bacteria. J. Antimicrob. Chemother. (1992) 30(Suppl. A):29–38.
   Google Scholar
• PASCULLE AW, LINDEN PK, MCDEVITT DA, WAGENER JL, MCKNIGHT JL, PAPAFRANGAS EA: Susceptibility of van-comycin-resistant Enterococcus faecium (VREF) to al-ternative antimicrobial agents singly and in combination. 33rd International Conference On Antimicro-bial Agents And Chemotherapy New Orleans, (1993), Abstr. 1060.
   Google Scholar
• BOUANCHAUD DH: /n vitro and in vivo synergic activity and fractional inhibitory concentration (FIC) of the components of a sernisynthetic streptogramin, RP
   Google Scholar
• J. Antimicrob. Chemother. (1992) 30(Suppl. A):95-99. A reference article on synergistic activity of streptogramin compo-nents
   Google Scholar
• CRAIG W, EBERT S: Pharmacodynamyc activities of RP59500 in an animal infection modeL 33rd International Conference On Antimicrobial Agents And Chemotherapy, New Orleans, (1993), Abstr. 470.
   Google Scholar
• CHIN NX, NEU HC: Post-antibiotic effect of RP 59500 against gram-positive bacteria compared to other agents. 31st International Conference On Antimicrobial Agents And Chemotherapy, Chicago, (1991), Abstr. 899.
   Google Scholar
• A relevant article on post-antibiotic effect
   Google Scholar
• NOUGAYREDE A, BERTHAUD N, BOUANCHAUD DH: Post-antibiotic effects of RP 59500 with Staphylococcus aureus. J. Antimicrob. Chemother. (1992) 30(Suppl. A):101–106.
   Google Scholar
• ROLIN O, BOUANCHAUD DH: in vivo efficacy of RP59500, a new synergistic antibacterial agent, in Staphy- lococcus aureus and in Streptococcus pneumoniae mouse experimental infections. 30th International Con-ference On Antimicrobial Agents And Chemotherapy, Atlanta, (1991), Abstr. 787.
   Google Scholar
• AZOULAY-DUPUIS E, VALLEE E, VEBER B, POCIDALO JJ: Activity of RP 59500, a new semisynthetic strepto-gramin, in mouse pneumonia induced by a macrolide-resistant strain of streptococcus pneumoniae. 31st International Conference On Antimicrobial Agents And Che-motherapy, (1991) Chicago, Abstr. 902.
   Google Scholar
• AZOULAY-DUPUIS E, VALLEE E, POCIDALO JJ: Efficacy of RP 59500, a new semisynthetk streptogramin, against penicillin-resistant and multiresistant strains of strep-tococcus pneumoniae. 32nd International Conference On Antimicrobial Agents And Chemotherapy, Anaheim, (1992), Abstr. 1311.
   Google Scholar
• CHAMBERS FIF: Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus. j Antimi-crob. Chemother. (1992) 30 (Suppl. A):117–122.
   Google Scholar
• FANTIN B., VALLOIS DM., OTTAVIANI M, MAZLERE B, GARRY L, POCIDALO B, CARBON C: Autoradiographic pattern of diffusion of 14C RP 59500 throughout infected cardiac vegetation in rabbits. 33rd International Confer-ence On Antimicrobial Agents And Chemotherapy New Or-leans, (1993), Abstr. 161.
   Google Scholar
• BERTHAUD N, MONTAY G, HUET Y, BOURGUES A, BUS-SIERE JC, SAUTEDE M, SELINGUE M, DESNOTTES JF: RP 59500, in vivo bactericidal activity in a model of S. aureus mouse infection: influence of varying the dos-age and the number of treatments. 32nd International Conference On Antimicrobial Agents And Chemotherapy Anaheim, (1992), Abstr. 1315.
   Google Scholar
• BERTHAUD N, ROMBI C, HURT Y, BOURGUES A, BUSSIERE JC, SAUTEDE M, SELINGUE M, DESNOTrES JF: RP 59500: In vivo bactericidal activity in Streptococcus pneumo-niae mouse septicemia. 33rd International Conference On Antimicrobial Agents And Chemotherapy New Orleans, (1993), Abstr. 1157.
   Google Scholar
• TURCO'I h A, BERGERON MG: Pharmacodynamic inter-action between RP 59500 and Gram-positive bacteria Infecting fibrin dots. Antimicrob. Agents Chemother. (1992) 36(10):2211–2215
   PubMed Web of Science ®Google Scholar
• DESNOTTES JF, DIALLO N: RP 59500:In vitro antistaphy-lococcal bactericidal activity across platelet-fibrin ma-trices compared to that of vancomycin. 33rd International Conference On Antimicrobial Agents And Che-motherapy New Orleans, (1993), Abstact 763.
   Google Scholar
• GEORGOPOULOS A, BREYER S, FEISTANER S, STAUFFER F, MARKRISTATHIS A, GEORGOPOULOS M., GRANINGER W: Bactericidal effect of RP 59500 against staphylococci with different phenotypes in a diffusion chamber model in rabbits. 32nd International Conference On An-timicrobial Agents And Chemotherapy Anaheim, (1992), Abstr. 1309.
   Google Scholar
• DESNOITIS JF, DIALLO N: Cellular uptake and intracel-lular bactericidal activity of RP 59500 in murine macro-phages. J. Antimicrob. Chemother. (1992) 30(Suppl. A):107–115.
   Google Scholar
• ETIENNE SD, MONTAY G, LE LIBOUX A, FRYDMAN A, GARAUD JJ: A phase I, double-blind, placebo-controlled study of the tolerance and phannacokinetic behaviour of RP 59500. J. Antimicrob. Chemother. (1992) 30(Suppl. A):123–131.
   Google Scholar
• The first study published on tolerance and pharmacokinetics of RP 59500 in man.
   Google Scholar